Exploring the Potential Mechanism of Qi-Shen-Di-Huang Drug Formulary for Myasthenia Gravis (MG) based on UHPLC-QE-MS Network Pharmacology and Molecular Docking Techniques

Myasthenia gravis (MG) is a rare and refractory autoimmune disease, and Qi Shen Di Huang (QSDH) drug formulary is an in-hospital herbal decoction with proven clinical efficacy in treating MG. Currently, most of the research on the QSDH drug formulary has concentrated on its clinical efficacy, and th...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yibin, Chang, Tianying, Lu, Qi, Cui, Yingzi, Zhang, Dongmei, Wang, Baitong, Xu, Peng, Lu, Jing, Ma, Jinhui, Lv, Zhiguo, Wang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550457/
https://www.ncbi.nlm.nih.gov/pubmed/36225188
http://dx.doi.org/10.1155/2022/7416448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9550457/
https://www.ncbi.nlm.nih.gov/pubmed/36225188
http://dx.doi.org/10.1155/2022/7416448

Ejemplares similares